Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Immunology | Musculoskeletal | Rheumatology | Family Medicine
Search Medical Condition
Rheumatoid Arthritis Clinical Trials
A listing of Rheumatoid Arthritis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (405) clinical trials
A Phase 3b/4 Randomized Double Blind Placebo Controlled Study Of Methotrexate (Mtx) Withdrawal In Subjects With Rheumatoid Arthritis (ra) Treated With Tofacitinib 11mg Modified Release (mr) Formulation
This study is designed to evaluate the efficacy and safety of tofacitinib modified release formulation (11mg QD) versus tofacitinib modified release formulation plus continued methotrexate treatment in subjects with moderate to severe rheumatoid arthritis who are insufficiently responding to their stable dose of methotrexate treatment.
A multi-center, randomized, double-blind, placebo controlled, parallel group study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of CFZ533 in patients with primary Sjögren’s syndrome
Winthrop University Hospital Clinical Trials Center in conjunction with The Division of Rheumatology and The Arthritis and Rheumatic Disease Center is conducting a clinical research study on an investigational medication, for patient with dry mouth associated with SjÖgren’s Syndrome. This study will evaluate the safety and effectiveness of an investigational ...
Rheumatoid Arthritis – Inadequate Response to MTX
A research study is evaluating an investigational medication for Rheumatoid Arthritis (RA). This research study may be an option if you: Are between 18 and 80 years of age (inclusive) Have been diagnosed with RA for at least 3 months Have received weekly methotrexate (MTX) treatment for at least 3 ...
FINCH 1: A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 weeks in Combination with Methotrexate to Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
FINCH 1 is enrolling RA patients who have taken methotrexate (also known as MTX, TREXALL, or RASUVO) but have not yet tried a biologic treatment. Filgotinib (study drug) is an oral medication designed to reduce joint inflammation.
FINCH 3: A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severely
FINCH 3 is enrolling patients who have not yet tried methotrexate (also known as MTX, TREXALL, or RASUVO) or who have only received limited treatment for RA.
FINCH 3: A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 Weeks Alone and in Combination with Methotrexate (MTX) to Subjects with Moderately to Severely
FINCH 3 is enrolling patients, who have not yet tried methotrexate (also known as; MTX, TrexaIl® or Rasuvo®) or who have only received limited treatment for RA.
FINCH 1: A Randomized, Double-blind, Placebo- and Active-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 52 weeks in Combination with Methotrexate to Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
FINCH 1 is enrolling RA patients, who have taken methotrexate (also known as; MTX, TrexaIl® or Rasuvo®) but have not yet tried a biologic treatment.
CREDO 2: A Randomized, Double Blind, Parallel Group, Placebo and Active Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy CREDO 3: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-a) Inhibitor Therapy
The purpose of this study is to determine the effectiveness of the investigational drug Olokizumab in patients living with Rheumatoid Arthritis (RA).
Rheumatoid arthritis can affect your daily life, don't let it win! Learn more about a new research study now enrolling.
Rheumatoid Arthritis is a chronic immune/inflammatory disease characterized by persistent synovitis. If you have a diagnosis of rheumatoid arthritis, a clinical research study could be an option for you. New England Research is currently conducting a study to test the safety and effectiveness of the the drug Olokizumab in patients ...
12 Month to assess the clinical and economic outcomes of Vectra DA guided treatment compared with usual care in subject with Rheumatoid Arthritis with inadequate response to MTX
Adults with Rheumatoid Arthritis with inadequate response to MTX may qualify to have Vectra DA guided treatment for 12 months.
